Literature DB >> 7947100

The impact of genetic counselling on risk perception in women with a family history of breast cancer.

D G Evans1, V Blair, R Greenhalgh, P Hopwood, A Howell.   

Abstract

Women with a family history of breast cancer generally self-refer because they have a feeling that their risk is high. However, they have, in general, only a hazy notion of the population risk of breast cancer and their own risk in relation to this. It is probable that they are helped by genetic counselling and, if at substantial risk, by annual mammography. However, the psychological impact of assigning true risk and the value of mammography need to be evaluated. We have assessed risk perception by questionnaire in 517 new referrals to a family history clinic and 200 women returning to the clinic at least 1 year after counselling. Correct assignment of population lifetime risk of breast cancer was 16% in the uninformed precounsel group and 33% in the post-counsel group, likewise personal risk was correct in 11% and 41% respectively. Post-counsel women were significantly more likely to retain information if they were sent a post-clinic letter or if they assessed their personal risk as too high initially.

Entities:  

Mesh:

Year:  1994        PMID: 7947100      PMCID: PMC2033538          DOI: 10.1038/bjc.1994.423

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families.

Authors:  B Newman; M A Austin; M Lee; M C King
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Risk perception, family history, and use of breast cancer screening tests.

Authors:  A P Polednak; D S Lane; M A Burg
Journal:  Cancer Detect Prev       Date:  1991

3.  Age at onset as an indicator of familial risk of breast cancer.

Authors:  E B Claus; N J Risch; W D Thompson
Journal:  Am J Epidemiol       Date:  1990-06       Impact factor: 4.897

4.  Molecular genetics. Colorectal cancer genes.

Authors:  E Solomon
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

5.  Patients' subjective interpretation of risks offered in genetic counselling.

Authors:  J H Pearn
Journal:  J Med Genet       Date:  1973-06       Impact factor: 6.318

6.  Mammographic screening of women with increased risk of breast cancer.

Authors:  V G Vogel; D S Graves; S W Vernon; J A Lord; R J Winn; G N Peters
Journal:  Cancer       Date:  1990-10-01       Impact factor: 6.860

7.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

8.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

9.  Mammography adherence and psychological distress among women at risk for breast cancer.

Authors:  C Lerman; M Daly; C Sands; A Balshem; E Lustbader; T Heggan; L Goldstein; J James; P Engstrom
Journal:  J Natl Cancer Inst       Date:  1993-07-07       Impact factor: 13.506

10.  Perception of risk in women with a family history of breast cancer.

Authors:  D G Evans; L D Burnell; P Hopwood; A Howell
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

View more
  46 in total

Review 1.  Setting up a breast cancer family history clinic.

Authors:  C Saunders; V Vijay; J Stein; M Baum
Journal:  Ann R Coll Surg Engl       Date:  1999-11       Impact factor: 1.891

Review 2.  Research issues in genetic testing of adolescents for obesity.

Authors:  Mary E Segal; Pamela Sankar; Danielle R Reed
Journal:  Nutr Rev       Date:  2004-08       Impact factor: 7.110

3.  The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Results from the National Health Interview Survey.

Authors:  C P Gross; G Filardo; H S Singh; A N Freedman; M H Farrell
Journal:  J Gen Intern Med       Date:  2005-12-22       Impact factor: 5.128

Review 4.  How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review.

Authors:  Stephanie Sivell; Glyn Elwyn; Clara L Gaff; Angus J Clarke; Rachel Iredale; Chris Shaw; Joanna Dundon; Hazel Thornton; Adrian Edwards
Journal:  J Genet Couns       Date:  2007-10-30       Impact factor: 2.537

5.  Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer.

Authors:  Cathrine Bjorvatn; Geir Egil Eide; Berit Rokne Hanestad; Nina Øyen; Odd E Havik; Anniken Carlsson; Gunilla Berglund
Journal:  J Genet Couns       Date:  2007-04       Impact factor: 2.537

6.  Subjective and Objective Risks of Carrying a BRCA1/2 Mutation in Individuals of Ashkenazi Jewish Descent.

Authors:  Kimberly Kelly; Howard Leventhal; Deborah Toppmeyer; Judy Much; James Dermody; Monica Marvin; Jill Baran; Marvin Schwalb
Journal:  J Genet Couns       Date:  2003-08       Impact factor: 2.537

7.  The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews.

Authors:  M B Hatcher; L Fallowfield; R A'Hern
Journal:  BMJ       Date:  2001-01-13

Review 8.  Risk assessment and management of high risk familial breast cancer.

Authors:  D G R Evans; F Lalloo
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

9.  Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment.

Authors:  J Westman; H Hampel; T Bradley
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

10.  Risk perception after genetic counseling in patients with increased risk of cancer.

Authors:  Johanna Rantala; Ulla Platten; Gunilla Lindgren; Bo Nilsson; Brita Arver; Annika Lindblom; Yvonne Brandberg
Journal:  Hered Cancer Clin Pract       Date:  2009-08-23       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.